236 related articles for article (PubMed ID: 30624640)
41. Analysis of the GCM2 gene in isolated hypoparathyroidism: a molecular and biochemical study.
Maret A; Ding C; Kornfield SL; Levine MA
J Clin Endocrinol Metab; 2008 Apr; 93(4):1426-32. PubMed ID: 18182452
[TBL] [Abstract][Full Text] [Related]
42. Is intraoperative parathyroid hormone monitoring necessary with ipsilateral parathyroid gland visualization during anticipated unilateral exploration for primary hyperparathyroidism: a two-institution analysis of more than 2,000 patients.
Rajaei MH; Oltmann SC; Adkisson CD; Elfenbein DM; Chen H; Carty SE; McCoy KL
Surgery; 2014 Oct; 156(4):760-6. PubMed ID: 25239313
[TBL] [Abstract][Full Text] [Related]
43. Study of parathyroid transcription factor Gcm2 expression in parathyroid lesions.
Nonaka D
Am J Surg Pathol; 2011 Jan; 35(1):145-51. PubMed ID: 21164298
[TBL] [Abstract][Full Text] [Related]
44. Dwarfs and Giants of Parathyroid Adenomas-No Difference in Outcome After Parathyroidectomy.
Abdel-Aziz TE; Gleeson F; Sadler G; Mihai R
J Surg Res; 2019 May; 237():56-60. PubMed ID: 30694792
[TBL] [Abstract][Full Text] [Related]
45. Creation of a "Wisconsin index" nomogram to predict the likelihood of additional hyperfunctioning parathyroid glands during parathyroidectomy.
Mazeh H; Chen H; Leverson G; Sippel RS
Ann Surg; 2013 Jan; 257(1):138-41. PubMed ID: 22801087
[TBL] [Abstract][Full Text] [Related]
46. Probability of Positive Genetic Testing Results in Patients with Family History of Primary Hyperparathyroidism.
El Lakis M; Nockel P; Gaitanidis A; Guan B; Agarwal S; Welch J; Simonds WF; Weinstein L; Marx S; Nilubol N; Patel D; Merkel R; Tirosh A; Kebebew E
J Am Coll Surg; 2018 May; 226(5):933-938. PubMed ID: 29408534
[TBL] [Abstract][Full Text] [Related]
47. EZH2 and ZFX oncogenes in malignant behaviour of parathyroid neoplasms.
Sanpaolo E; Miroballo M; Corbetta S; Verdelli C; Baorda F; Balsamo T; Graziano P; Fabrizio FP; Cinque L; Scillitani A; Muscarella LA; Guarnieri V
Endocrine; 2016 Oct; 54(1):55-59. PubMed ID: 26876532
[TBL] [Abstract][Full Text] [Related]
48. Multiple endocrine neoplasia type 1 (MEN1) gene mutations in a subset of patients with sporadic and familial primary hyperparathyroidism target the coding sequence but spare the promoter region.
Karges W; Jostarndt K; Maier S; Flemming A; Weitz M; Wissmann A; Feldmann B; Dralle H; Wagner P; Boehm BO
J Endocrinol; 2000 Jul; 166(1):1-9. PubMed ID: 10856877
[TBL] [Abstract][Full Text] [Related]
49. Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.
Costa-Guda J; Arnold A
Mol Cell Endocrinol; 2014 Apr; 386(1-2):46-54. PubMed ID: 24035866
[TBL] [Abstract][Full Text] [Related]
50. Expression and somatic mutations of SDHAF2 (SDH5), a novel endocrine tumor suppressor gene in parathyroid tumors of primary hyperparathyroidism.
Starker LF; Delgado-Verdugo A; Udelsman R; Björklund P; Carling T
Endocrine; 2010 Dec; 38(3):397-401. PubMed ID: 20972721
[TBL] [Abstract][Full Text] [Related]
51. A Possible Link Between Parathyroid Hormone Secretion and Local Regulation of GABA in Human Parathyroid Adenomas.
Hong AR; Kim YA; Bae JH; Min HS; Kim JH; Shin CS; Kim SY; Kim SW
J Clin Endocrinol Metab; 2016 Jun; 101(6):2594-601. PubMed ID: 27070188
[TBL] [Abstract][Full Text] [Related]
52. Molecular pathogenesis of parathyroid tumours.
Cinque L; Pugliese F; Salcuni AS; Scillitani A; Guarnieri V
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):891-908. PubMed ID: 30477753
[TBL] [Abstract][Full Text] [Related]
53. Molecular genetics and epigenetics of nonfamilial (sporadic) parathyroid tumours.
Westin G
J Intern Med; 2016 Dec; 280(6):551-558. PubMed ID: 27071708
[TBL] [Abstract][Full Text] [Related]
54. Familial isolated primary hyperparathyroidism due to HRPT2 mutation.
Ghemigian A; Ghemigian M; Popescu I; Vija L; Petrova E; Dumitru N; Dumitru I
Hormones (Athens); 2013; 12(3):454-60. PubMed ID: 24121387
[TBL] [Abstract][Full Text] [Related]
55. Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort.
Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Pareja R; Muntean A; Arsentales V; Caixàs A; Rigla M
Front Endocrinol (Lausanne); 2023; 14():1244361. PubMed ID: 37810884
[TBL] [Abstract][Full Text] [Related]
56. A garden of parathyroid adenomas.
Sahli ZT; Karipineni F; Zeiger MA
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28775107
[TBL] [Abstract][Full Text] [Related]
57. Allelic imbalance in sporadic parathyroid carcinoma and evidence for its de novo origins.
Costa-Guda J; Imanishi Y; Palanisamy N; Kawamata N; Phillip Koeffler H; Chaganti RS; Arnold A
Endocrine; 2013 Oct; 44(2):489-95. PubMed ID: 23435613
[TBL] [Abstract][Full Text] [Related]
58. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
[TBL] [Abstract][Full Text] [Related]
59. Genotype-Phenotype Correlations in Asian Indian Children and Adolescents with Primary Hyperparathyroidism.
Sharma A; Memon S; Lila AR; Sarathi V; Arya S; Jadhav SS; Hira P; Garale M; Gosavi V; Karlekar M; Patil V; Bandgar T
Calcif Tissue Int; 2022 Sep; 111(3):229-241. PubMed ID: 35567607
[TBL] [Abstract][Full Text] [Related]
60. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
